Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicon™ peptide platform to drug historically ...

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

SpringWorks Therapeutics, a subsidiary of German drugmaker Merck KGaA (MRK: DE), today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing ...

University of Pennsylvania Perelman School of Medicine and Yale University School of Medicine, along with other collaborators, report that lung adenocarcinoma can engage nerve pathways that link the ...

Cancer growth is shaped not only by malignant cells but by subtle changes in the immune environment surrounding them. New findings point to a shift in neutrophil behavior within tumours that ...